HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theodora Hatziioannou Selected Research

Broadly Neutralizing Antibodies

1/2016Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Theodora Hatziioannou Research Topics

Disease

44COVID-19
02/2024 - 01/2020
42Infections
10/2023 - 06/2002
5Virus Diseases (Viral Diseases)
02/2024 - 01/2007
4Severe Acute Respiratory Syndrome
01/2024 - 01/2021
4Vesicular Stomatitis
12/2021 - 10/2019
4Acquired Immunodeficiency Syndrome (AIDS)
10/2014 - 10/2006
3Breakthrough Infections
12/2022 - 10/2021
3Reinfection
01/2022 - 01/2021
2Pneumonia (Pneumonitis)
01/2021 - 01/2021
1Convalescence
10/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Viral Zoonoses
02/2009
1Fasciculation (Fasciculations)
05/2005

Drug/Important Bio-Agent (IBA)

32AntibodiesIBA
02/2024 - 04/2007
22Neutralizing AntibodiesIBA
02/2024 - 07/2020
19VaccinesIBA
10/2022 - 10/2006
8EpitopesIBA
01/2023 - 04/2007
7Monoclonal AntibodiesIBA
01/2023 - 06/2020
7Messenger RNA (mRNA)IBA
01/2023 - 01/2021
6Proteins (Proteins, Gene)FDA Link
01/2024 - 05/2005
6mRNA VaccinesIBA
12/2022 - 06/2021
6AntigensIBA
08/2022 - 01/2021
5Antiviral Agents (Antivirals)IBA
01/2021 - 06/2020
4Single-Domain AntibodiesIBA
12/2021 - 01/2021
2Glycoproteins (Glycoprotein)IBA
02/2024 - 06/2023
2Polysaccharides (Glycans)IBA
01/2024 - 06/2023
2N-(2-cyanoethylene)urea (BA 1)IBA
10/2023 - 12/2022
2BNT162 VaccineIBA
12/2021 - 10/2021
2Explosive Agents (Explosives)IBA
11/2020 - 06/2020
2env Gene ProductsIBA
01/2016 - 10/2014
2Bone Marrow Stromal Antigen 2IBA
06/2014 - 02/2009
2Complementary DNA (cDNA)IBA
03/2008 - 01/2007
1COVID-19 VaccinesIBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
12/2021
12019-nCoV Vaccine mRNA-1273IBA
10/2021
1crexavibartIBA
01/2021
1ogalvibartIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1EnzymesIBA
11/2020
1ImmunosorbentsIBA
11/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Broadly Neutralizing AntibodiesIBA
01/2016
1InterferonsIBA
10/2013
1Cyclophilin AIBA
03/2008
1moesinIBA
01/2007
1Tripartite Motif ProteinsIBA
09/2006
1Carrier Proteins (Binding Protein)IBA
05/2005
1Protein Kinase CIBA
05/2005
1Circular DNAIBA
05/2005
1Viral DNAIBA
05/2005
1Antiviral Restriction FactorsIBA
06/2004
1Capsid Proteins (Capsid Protein)IBA
06/2004
1Peptide Hydrolases (Proteases)FDA Link
09/2002
1polycationsIBA
06/2002
1Cyclophilins (Cyclophilin)IBA
06/2002
1polyanionsIBA
06/2002
1GlycosaminoglycansIBA
06/2002

Therapy/Procedure

4Therapeutics
01/2023 - 12/2012
1Immunotherapy
01/2021
1Highly Active Antiretroviral Therapy (HAART)
01/2019
1Chemoprevention
03/2009